The heart's structural integrity depends on microscopic cellular glue
In short: Imagine a brick wall without cement. This is the biological reality of arrhythmogenic cardiomyopathy (ACM). When specialized proteins fail to bond heart muscle cells together, the heart's architecture weakens, potentially leading to dangerous arrhythmias and sudden cardiac events.
Arrhythmogenic cardiomyopathy (ACM) is a rare genetic condition characterized by structural weaknesses in the heart. At its core, the pathology stems from a defect in specific proteins that function like 'glue' within the heart muscle cells. When these proteins fail to hold the cells together properly, the walls of the heart can become weak and may struggle to pump blood efficiently.
Historically, this condition was primarily referred to as arrhythmogenic right ventricular cardiomyopathy (ARVC) because it was believed to affect only the right ventricle. However, modern research has clarified that ACM can impact either the left or right ventricles, or both simultaneously. In some instances, it is also referred to as arrhythmogenic right ventricular dysplasia (ARVD). The condition is considered very rare in the general population. It can also be identified as arrhythmogenic right ventricular dysplasia.
The condition often involves a fibrofatty replacement of the right ventricular muscle, which creates an environment prone to arrhythmias. Since it usually stems from genetics, offspring of a parent with the condition face a 50/50 probability of receiving that specific gene mutation. However, inheriting the gene does not guarantee the development of the disease; some individuals remain 'carriers' who may never develop symptoms. Genetic mutations are caused by changes in one or more of your genes. These inherited traits determine who you are and are passed from parents to children.
While the risk of sudden cardiac events is a primary concern for clinicians, many people living with ACM can lead normal lives. Management focuses on diagnostic investigations and treatment options designed to monitor arrhythmic risk and prevent complications. Some people with this condition do not experience any symptoms at all. Specialists offer genetic information services to help families understand their specific risks.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Arrhythmogenic right ventricular cardiomyopathy (ARVC) - pathophysiology, investigations, treatment
- Also: Arrhythmogenic cardiomyopathy (ACM)
To cite this card, link to https://intellectplus.co.uk/app/science-arrhythmogenic-right-ventricular-cardiomyopathy-arvc-pathoph.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Science · Latest · A–Z · All topics
